Results

Total Results: 2,890 records

Showing results for "disease".

181. Disposition of Comments Report for Enzyme-Replacement Therapies for Lysosomal Storage Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
     January 01, 2014 - Enzyme-Replacement Therapies for Lysosomal Storage Diseases Technical Brief No. 12. … Different diseases and outcome measures are consolidated into one sentence. … There is potential for confusion that all measures apply to all diseases. … We have deleted all reference to disease incidence or prevalence among individual diseases from Table … as well as understanding the natural history and epidemiology of these diseases.

182. Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Related Risk Factors | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/sodium-potassium/research-protocol
     March 01, 2017 - The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes … "[Mesh] OR "Kidney Diseases"[Mesh] OR cardiovascular disease*[tiab] OR acute coronary syndrome*[tiab] … filtration" OR "end stage kidney disease"[tiab] OR "Kidney Diseases"[Mesh] OR chronic kidney disease … "[Mesh] OR "Kidney Diseases"[Mesh] OR cardiovascular disease*[tiab] OR acute coronary syndrome*[tiab] … filtration" OR "end stage kidney disease"[tiab] OR "Kidney Diseases"[Mesh] OR chronic kidney disease

183. Discontinuation of Disease-Modifying Treatment for Multiple Sclerosis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/multiple-sclerosis/research-protocol
     December 17, 2013 - However, generally people will reach a stage in their personal disease course where disease modifying … of the disease in the long-run and when to discontinue disease-modifying treatment. … What are patient and provider preferences for discontinuation of disease–modifying therapies? … When should a patient discontinue disease-modifying treatment? … FDA-approved disease modifying drugs were only available after 1993.

184. Appendix A - The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/risk-cardiovascular-disease-appendix-a.pdf
     August 31, 2023 - Appendix A - The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular Disease … Citations, Daily and Versions 1946 to August 31, 2023 Search Strategy: # Searches 1 exp Cardiovascular Diseases … cerebrovascular) adj3 ("adverse event*" or anomaly or anomalies or abnormalit* or defect or defects or disease … 37 remove duplicates from 36 38 33 or 35 or 37 ClinicalTrials.Gov Condi�on or Disease … Cardiovascular disease Other terms "2-Hydroxypropyl-beta-cyclodextrin" OR "alimentary carbohydrate

185. Effects of Dietary Sodium and Potassium Intake on Chronic Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/sodium-potassium_research-protocol.pdf
     April 18, 2017 - The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes … "[Mesh] OR "Kidney Diseases"[Mesh] OR cardiovascular disease*[tiab] OR acute coronary syndrome*[tiab … OR "glomerular filtration" OR "end stage kidney disease"[tiab] OR "Kidney Diseases"[Mesh] OR chronic … "[Mesh] OR "Kidney Diseases"[Mesh] OR cardiovascular disease*[tiab] OR acute coronary syndrome*[tiab … OR "glomerular filtration" OR "end stage kidney disease"[tiab] OR "Kidney Diseases"[Mesh] OR chronic

186. Mortality Risk in Chronic Obstructive Pulmonary Disease Patients Using Theophylline | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/copd-management/research
     December 04, 2009 - Mortality Risk in Chronic Obstructive Pulmonary Disease Patients Using Theophylline Research Report … Participants Patients with a diagnosis of chronic obstructive pulmonary disease that were 45 years … adn Main Results Primary outcome measures were all-cause mortality, chronic obstructive pulmonary disease … exacerbations and chronic obstructive pulmonary disease-related hospitalizations. … that included theophylline had slightly increased risks of mortality, chronic obstructive pulmonary disease

187. The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/risk-cardiovascular-disease.pdf
     January 01, 2023 - and 9 years (before puberty) o Between 9 and17 years o 18 years and older • Participants with diseases … disease) o Stroke o Cardiovascular disease- related mortality • Hypertensive disorders during … , stroke, and cardiovascular disease-related mortality. … Diet, nutrition and the prevention of chronic diseases. … Dietary carbohydrates: role of quality and quantity in chronic disease.

188. - (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease-future_research.pdf
     July 01, 2016 - history of the disease. … by the AGA9 including the introduction of biologics into the treatment algorithm for inflammatory diseases … history of the disease. … by the AGA9 including the introduction of biologics into the treatment algorithm for inflammatory diseases … Review article: Crohn's disease: monitoring disease activity.

189. Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
     January 01, 2013 - has asymptomatic disease), diagnosis (who has symptomatic disease), staging (how advanced is the disease … disease). … American Journal of Kidney Diseases 1997 Dec;30(6):814-21. PMID: 9398126. 17. … American Journal of Kidney Diseases 1999 Jul;34(1):29-35. PMID: 10401012. 24. … American Journal of Kidney Diseases 1997 Dec;30(6):912-22. PMID: 9398141. 33.

190. Disposition of Comments for CER 171 Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_disposition-comments.pdf
     March 29, 2016 - Disposition of Comments for CER 171 Noninvasive Testing for Coronary Artery Disease Comparative Effectiveness … Noninvasive Testing for Coronary Artery Disease. Comparative Effectiveness Review No. 171. … Outcomes of anatomical versus functional testing for coronary artery disease. … and patients who have some coronary disease. … Outcomes of anatomical versus functional testing for coronary artery disease.

191. Chronic Kidney Disease Stages 1-3: Screening, Monitoring, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
     August 01, 2012 - No mention of auto immune diseases such as vasculitis? 1. … did not identify trials that reported a substantial prevalence of vasculitis or other auto immune diseases … ―CKD as an Underrecognized Threat to Patient Safety.‖ American Journal of Kidney Diseases, Vol 53, … The draft CER focuses on endpoints for end-stage renal disease (ESRD), cardiovascular disease (CVD) … The overlap of co-morbid diseases is common enough that in the case of isolated CKD, there is likely

192. Future Research Needs for Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/heart-disease-ace-inhibitor-arb-future/research

193. Drug Therapy for Early Rheumatoid Arthritis in Adults – An Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine-update/research-protocol
     May 24, 2017 - risk. 10 Burden of Disease Disability associated with RA is significant. … activity thresholds: High disease activity >5.1; Low disease activity <3.2; Remission <2. … Atlanta, GA: Centers for Disease Control and Prevention; 2017. … The microbiome in infectious disease and inflammation. … Rheumatoid arthritis management of early disease.

194. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/chronic-kidney-disease
     December 02, 2020 - Topic Suggestion Disposition [PDF · 372.1 KB] Patient Activation Interventions for Chronic Kidney Disease … With the rapid growth in the number of Americans who face chronic kidney disease (CKD) and end-stage … community-level health needs linked to these diseases. … Compounding this trend, more than 75%of those living with kidney disease in America have one or more … In absence of this understanding and changes in care practices, those with kidney disease may continue

195. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/na-liver-disease
     July 17, 2020 - Suggestion Disposition [PDF · 543.2 KB] Screening, Preventing, and Treating Non-Alcoholic Fatty Liver Disease … We are interested in the screening, prevention, and treatment of non-alcoholic fatty liver disease (NAFLD … Primary care providers often do not screen patients at risk for NAFLD which enables the disease to progress … How well does diet and exercise manage or reverse the disease? 

196. Fifth Journal Supplement on Research Methods: Patient-Centered Health Outcomes in Rare Diseases | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/rare-diseases-outcomes/executive
     July 24, 2014 - Authors with abstracts that were highly rated by a panel of rare disease experts were invited to submit … Quantifying a Rare Disease in Administrative Data: The Example of Calciphylaxis Nigwekar SU, Solid CA … Quantifying a Rare Disease in Administrative Data: The Example of Calciphylaxis. … Important Role of Translational Science in Rare Disease Innovation, Discovery, and Drug Development … Important Role of Translational Science in Rare Disease Innovation, Discovery, and Drug Development.

197. Geographic Variation in Carotid Endarterectomy and Carotid Stenting Among Medicare Beneficiaries, 2003-2006 | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cardiology-health-outcomes/research
     July 28, 2010 - the 365 days preceding the intervention date for evidence of cancer ( International Classification of Diseases … We also searched for evidence of peripheral vascular disease (ICD-9-CM codes 443.9, 441.x, 785.4, and … V43.4) and cerebrovascular disease (codes 434.x-438.x). … disease. … peripheral vascular disease, and 60.6% had a prior diagnosis of cerebrovascular disease.

198. Treatment Intensification in Type 2 Diabetes Mellitus | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/diabetes-treatment/abstract
     January 24, 2012 - patients with type 2 diabetes mellitus (DM) may have other major illnesses including heart and kidney disease … versus treatment with an additional oral antidiabetic agent, benefits patients with cardiovascular disease … (CVD) and/or chronic kidney disease (CKD). … CKD; b) progression of CVD (acute myocardial infarction and stroke), CKD (including End Stage Renal Disease … Expected date of project completion: Winter 2013 EHC Priority Condition(s): Diabetes, Cardiovascular Disease

199. Ácidos grasos omega-3 y la enfermedad cardiovascular | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/fatty-acids-cardiovascular-disease/espanol
     October 30, 2017 - información La información de este resumen proviene del informe Omega-3 Fatty Acids and Cardiovascular Disease … Esta guía fue traducida de la publicación en inglés titulada Omega-3 Fatty Acids and Cardiovascular Disease

200. The Performance of Fusion Procedures for Degenerative Disease of the Lumbar Spine (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-spinal-fusion-key-question.pdf
     January 01, 2023 - The Performance of Fusion Procedures for Degenerative Disease of the Lumbar Spine 1 The Performance … of Fusion Procedures for Degenerative Disease of the Lumbar Spine DRAFT KEY QUESTIONS (KQs) … KQ4: Among patients with chronic low-back pain resulting from degenerative disease of the lumbar spine … Trends in Lumbar Fusion Procedure Rates and Associated Hospital Costs for Degenerative Spinal Diseases … rate and influence of surgery-related factors in lumbar interbody arthrodesis for degenerative spine diseases